Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Shareholders Equity (Tables)

v3.23.2
Shareholders Equity (Tables)
 6 Months Ended
Jun. 30, 2023
Shareholders Equity [Abstract]  
Schedule of Share Options and Their Weighted Average Exercise Price The following table lists the number of share options and their weighted average exercise prices in option plans of employees, directors and consultants for the six months period ended June 30, 2023 and related information:
    Number of options     Weighted
average
exercise
price		     Weighted
average
remaining
contractual
terms
(in years)		     Aggregate
intrinsic
value		  
                         
Outstanding at December 31, 2022     27,002,200       0.13       7.14      
     -
  
Grants     15,500,000       0.01       -       -  
Forfeited/expired     (25,200 )     4.05       -       -  
                                 
Outstanding at June 30, 2023     42,477,000       0.08       7.83      
-
  
                                 
Vested and expected to vest at June 30, 2023     42,477,000       0.08       7.83      
-
  
                                 
Exercisable at June 30, 2023     14,217,625       0.17       6.61      
-